CLINICAL TRIAL

AC+RwdC for Treatment Adherence

Waitlist Available · 18+ · All Sexes · Phoenix, AZ

Incentivizing Meditation App Habit Formation: A Randomized Controlled Trial

See full description

About the trial for Treatment Adherence

Eligible Conditions
Treatment Adherence · Stress (Psychology)

Treatment Groups

This trial involves 3 different treatments. AC+RwdC is the primary treatment being studied. Participants will be divided into 2 treatment groups. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Experimental Group 1
AC+ARwdC
BEHAVIORAL
Experimental Group 2
AC+RwdC
BEHAVIORAL
Control Group 3
Usual Calm Control (UC)
BEHAVIORAL

Eligibility

This trial is for patients born any sex aged 18 and older. There are 7 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
Able to read/understand English
Have access to a smartphone on a daily basis
Reside in the US or a US territory
Willing to be randomized
You have a perceived stress scale score greater than or equal to 15. show original
You are at least 18 years old. show original
You have purchased a minimum of 1 year membership. show original
View All
Odds of Eligibility
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Similar Trials

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: Change from post-intervention (week 8) to follow-up (week 16)
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: Change from post-intervention (week 8) to follow-up (week 16).
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether AC+RwdC will improve 2 primary outcomes and 6 secondary outcomes in patients with Treatment Adherence. Measurement will happen over the course of Change from baseline to post-intervention (week 8).

Mean Adherence Persistence Over Weeks 1-8
CHANGE FROM BASELINE TO POST-INTERVENTION (WEEK 8)
Mean Adherence Persistence over weeks 1-8 will be measured using Calm app usage data from weeks 1-8 of the study, retrieved from the Calm informatics team (with the participant permission). Mean adherence is measured as the percent of days per week with any meditation.
Habit Strength
CHANGE FROM BASELINE TO POST-INTERVENTION (WEEK 8) TO FOLLOW-UP (WEEK 16)
Habit Strength will be measured with the Self-Report Habit Index. Higher scores on the SRHI indicate greater habit strength.
Sleep Disturbances
CHANGE FROM BASELINE TO POST-INTERVENTION (WEEK 8) TO FOLLOW-UP (WEEK 16)
Sleep Disturbances will be measured with the Insomnia Severity Index. Scores on the ISI range from 0-28 with higher score indicates more severe insomnia.
PTSD
CHANGE FROM BASELINE TO POST-INTERVENTION (WEEK 8) TO FOLLOW-UP (WEEK 16)
PTSD will be measured using the Impact of Events Scale-Revised. Scores on the IES-R range from 0-88 with higher scores indicating greater severity of PTSD symptoms.
Anxiety
CHANGE FROM BASELINE TO POST-INTERVENTION (WEEK 8) TO FOLLOW-UP (WEEK 16)
Anxiety will be measured using the Hospital Anxiety and Depression Scale (Anxiety Subscale). Scores on the HADS Anxiety Subscale range from 0-21 with higher scores indicating greater anxiety.
Stress
CHANGE FROM BASELINE TO POST-INTERVENTION (WEEK 8) TO FOLLOW-UP (WEEK 16)
Stress will be measured using the Perceived Stress Scale. Scores on the PSS-10 range from 0-40 with greater scores indicating greater stress.
See More

Patient Q & A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is stress (psychology)?

Stress is seen as the challenge and fight-or-flight response to stressors that produce physiological and emotional effects and is characterized by a range of associated traits including subjective emotional arousal, behaviour, and physiological reactions with the ultimate goal of avoiding, reducing, or escaping the threat or stressor. \n

Anonymous Patient Answer

Can stress (psychology) be cured?

Stress (psychology) may affect other psychiatric disorders and hence needs to be kept under medical control. It is not so obvious what will be the ultimate outcome of stress (psychology) treatment. Thus, it is imperative that stress (psychology) be studied as an approach to cure.

Anonymous Patient Answer

What causes stress (psychology)?

As people start getting older, their coping skills are often not as well developed, resulting in stress. Stress can cause a lot of physical and psychological symptoms, including cardiovascular diseases, as well as gastrointestinal and mood disorders.

Anonymous Patient Answer

What are common treatments for stress (psychology)?

These are a variety of options that are used to treat stress (psychology). They include psychotherapy, therapy, medications, and other supportive care. Generally supportive care focuses on the person rather than their environment. Stress (psychology) is a very common issue in the medical field that may be treated through psychological approaches to manage or manage psychological stress.\n

Anonymous Patient Answer

How many people get stress (psychology) a year in the United States?

Between 12.7 and 15.6 per 1000 US adults are diagnosed with CFS/ME a year. Around 12.4 per 1000 US adults have anxiety disorders/compensatory behaviour a year. In the USA, between 4.6 and 6 per 1000 US adults have depression a year.

Anonymous Patient Answer

What are the signs of stress (psychology)?

The stressors included the sudden death of a spouse, the loss of a job, the breakup of a long-standing relationship, or the discovery that cancer has recurred or spread. Some symptoms of stress were found to be specific to each stressful situation, and can be used to diagnose and treat the type of stress experienced.

Anonymous Patient Answer

Have there been any new discoveries for treating stress (psychology)?

In a recent study, findings from this study suggest that yoga may be a therapy that can reduce symptoms of stress (psychology). Moreover, yoga may be a new method for relieving stress symptoms and treating anxiety disorders. This would be a great contribution for researchers and healthcare professionals that struggle with stress (psychology).

Anonymous Patient Answer

What are the common side effects of ac+arwdc?

When prescribing ac+arwdc the most common adverse effects were injection site pain/itch(30%), abdominal pain(21%), headache(19%), diarrhoea(18%), dizziness(16%), nausea(13%), blurred vision(3%), rash(3%), fatigue(3%), pruritic(2%), flu-like symptoms(2%), cough(2%), weight change(2%), constipation(2%), fatigue(2%), nausea(2%), and abnormal vision(2%). In 3 of 25 patients, the headache and dizziness were of a severity that would be classed as ‘severe’, and they prompted the patient to start going to the doctor to do further tests.

Anonymous Patient Answer

What are the latest developments in ac+arwdc for therapeutic use?

The most recent research on ACWD has demonstrated improved patient outcomes, increased patient acceptance of treatment, and decreased the number of ACWD treatments in a clinical setting. This increased acceptance may lead to cost-effectiveness and improved outcomes.

Anonymous Patient Answer

How serious can stress (psychology) be?

The findings support a link between psychosocial factors and disease severity in sicca. The findings also support the hypothesis that stress (psychology) has its effects mainly by affecting inflammatory pathways during the development of a neoplastic disease, and that the effect is amplified by disease-related factors, including malignancy.

Anonymous Patient Answer

How does ac+arwdc work?

The findings indicate that ARWDc as a whole may represent a cost-effective means of prevention or treatment of depression in high risk populations, particularly in adolescents and young mothers. More specifically, the findings suggest that ARWDc as a preventive measure represents an option in situations that would be less sensitive to the limitations introduced by other interventions.

Anonymous Patient Answer

Does stress (psychology) run in families?

The present cross-cultural study of family variables can be an important tool to investigate the relationships between temperament traits and the psychobiological aspects of health.

Anonymous Patient Answer
See if you qualify for this trial
Get access to this novel treatment for Treatment Adherence by sharing your contact details with the study coordinator.